S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates as CETP inhibitors

Bioorg Med Chem Lett. 2004 May 17;14(10):2589-91. doi: 10.1016/j.bmcl.2004.02.071.

Abstract

Studies on the relationship between the structure of the benzene moiety of S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates and CETP inhibitory activity were performed. Substituents on the benzene moiety influenced CETP inhibitory activity in a type and position dependent manner, and electron-withdrawing groups at the 4- or 5-position increased the activity. The most potent compound showed 50% inhibition of CETP activity in human plasma at a concentration of 2 microM.

MeSH terms

  • Amides
  • Arteriosclerosis / prevention & control
  • Carrier Proteins / antagonists & inhibitors*
  • Carrier Proteins / blood
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL / agonists
  • Esters
  • Glycoproteins / antagonists & inhibitors*
  • Glycoproteins / blood
  • Humans
  • Inhibitory Concentration 50
  • Protective Agents / chemical synthesis
  • Protective Agents / pharmacology
  • Quinolines
  • Structure-Activity Relationship
  • Sulfhydryl Compounds / chemical synthesis
  • Sulfhydryl Compounds / pharmacology*

Substances

  • Amides
  • CETP protein, human
  • Carrier Proteins
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Esters
  • Glycoproteins
  • Protective Agents
  • Quinolines
  • Sulfhydryl Compounds
  • dalcetrapib
  • torcetrapib